Names & News

Posted: February 2017 Keith Kerr received the 2016 IASLC Mary J. Matthews Pathology/ Translational Research Award, which is given to a scientist for lifetime scientific achievements in pathology/translational research of thoracic […]

Posted: February 2017 Roy S. Herbst received the 2016 IASLC Paul A. Bunn, Jr. Scientific Award, which is given to an oncologist who has made outstanding scientific contributions to thoracic cancer […]

Posted: February 2017 Peter Hammerman has been appointed Global Head, Oncology Translational Research at Novartis Institutes for BioMedical Research (NIBR). Previous to this appointment, Dr. Hammerman was a Medical Oncologist and […]

Thomas Stinchcombe has been recruited to the Duke Cancer Institute (DCI) where he will be promoted to Professor of Medicine in Medical Oncology. Tom will help lead the thoracic oncology group […]

Charles B. Simone II has been appointed the Medical Director of the Maryland Proton Treatment Center (MPTC). Previous to this appointment, Dr. Simone was Associate Professor of Radiation Oncology at […]

Tony Mok has been selected by the American Society of Clinical Oncology (ASCO) as a candidate for the 2017 ASCO Board of Directors. Professor Mok is a professor in the Department […]

Richard B. Gaynor will retire as Senior Vice President, Global Development and Medical Affairs, Lilly Oncology as of January 2017. Prior to joining Lilly, Dr. Gaynor was a professor of medicine […]

Martin J. Edelman has been appointed Chairman of the Department of Hematology/Oncology and Deputy Director for Clinical Research at the Fox Chase Cancer Center in Philadelphia. He will also be the […]

Dr. Philip Bonomi completed his service as Director of the Division of Hematology, Oncology and Cell Therapy at Rush University Medical Center, Chicago, US, a position he has held since […]

David Ball was appointed Director of the Lung Tumour Stream for The Royal Melbourne Hospital, The Royal Women’s Hospital and the Peter MacCallum Cancer Centre, which are now part of […]